Khadiga Z Farid

Title: Khadiga Z Farid: Innovator in Antibacterial Peptide Research

Introduction

Khadiga Z Farid is a prominent inventor based in Lebanon, Indiana, known for her significant contributions to the field of antibacterial peptide research. With a total of two patents to her name, she has made strides in developing new pharmaceutical formulations that target Gram-positive bacteria.

Latest Patents

Her latest patents focus on two new groups of A-21978C cyclic peptides, specifically anhydro- and isomer-A21978C peptide derivatives. These innovative compounds exhibit antibacterial activity and serve as useful intermediates in pharmaceutical applications. The peptides are synthesized through transpeptidation of the parent cyclic peptides. Furthermore, her inventions include pharmaceutical formulations that utilize these new peptides as active ingredients, along with methods for treating infections caused by susceptible Gram-positive bacteria. Additionally, the patents provide an antibacterial composition containing the new drug substance LY 146032 in a substantially pure form.

Career Highlights

Khadiga Z Farid is currently employed at Eli Lilly and Company, where she continues to advance her research in the pharmaceutical field. Her work has the potential to significantly impact the treatment of bacterial infections, showcasing her dedication to innovation in healthcare.

Collaborations

She collaborates with notable colleagues, including Patrick J Baker and Manuel Debono, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Khadiga Z Farid's work in developing antibacterial peptides represents a significant advancement in pharmaceutical research. Her contributions are poised to enhance treatment options for bacterial infections, reflecting her commitment to improving public health through innovation.